Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.302 EUR | +4.14% | -2.27% | -22.56% |
Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.56% | 13.06M | |
+31.83% | 50.85B | |
+0.90% | 42.82B | |
+48.77% | 42.03B | |
-4.22% | 29.55B | |
+10.93% | 26.11B | |
-22.03% | 19.13B | |
+7.59% | 13.05B | |
+26.54% | 12.16B | |
+23.23% | 12.08B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Transcript : Celyad Oncology SA, H1 2022 Earnings Call, Aug 05, 2022